{"title":"Best sellers","description":"\u003cp\u003eOur most requested compounds: weight management, sexual health, and all-time favorites.\u003c\/p\u003e","products":[{"product_id":"retatrutide-20-mg","title":"Retatrutide","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eThe most potent metabolic peptide in the literature today. It acts \u003cstrong\u003eon three switches at once\u003c\/strong\u003e for appetite and energy expenditure, instead of on just one like earlier-generation compounds.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eYour body has several hormones that tell the brain “that's enough, stop eating.” Retatrutide mimics three of them simultaneously. The first two reduce hunger; the third also makes the body burn more. That is why the published figures are higher than those of any other compound in its family.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on body weight and appetite control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body recomposition studies: how much fat is lost and how much muscle is preserved\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Energy expenditure: the branch that sets it apart from the rest\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Fatty liver and blood sugar control\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder. It is reconstituted with bacteriostatic water, swirled without shaking until dissolved, and stored between 2 and 8 °C. In the literature it is administered once a week, always with gradual dose escalation: increasing slowly is what reduces digestive discomfort \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In the phase 2 trial (338 adults, 48 weeks), the 12 mg dose produced a mean body weight reduction of \u003cstrong\u003e24.2%\u003c\/strong\u003e, versus 2.1% with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  At 8 mg, 100% of participants lost at least 5% of their weight, 91% at least 10%, and 75% at least 15% \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  A phase 2a trial in metabolic fatty liver disease described significant reductions in liver fat content \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Digestive effects were the most frequent: they were dose-dependent, mostly mild or moderate, and were attenuated by starting with a lower initial dose \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  A dose-dependent increase in heart rate was observed, peaking at 24 weeks and declining thereafter \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGIP \/ GLP-1 \/ glucagon triple agonism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eRetatrutide (LY-3437943) acts as an agonist of the glucose-dependent insulinotropic polypeptide, glucagon-like peptide-1 and glucagon receptors \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e. The first two branches reduce intake centrally and slow gastric emptying.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eThe glucagon branch\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis is what sets it apart from dual agonists. Signaling through the glucagon receptor is associated with increased energy expenditure and mobilization of liver fat, so energy balance is addressed from both sides: less in and more out \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eClinical development\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt has completed phase 2 in obesity and in metabolic dysfunction-associated steatotic liver disease, and is in registrational phase 3 in obesity, sleep apnea and knee osteoarthritis, as well as type 2 diabetes \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical and top-tier.\u003c\/strong\u003e The data come from randomized, placebo-controlled clinical trials published in \u003cem\u003eThe New England Journal of Medicine\u003c\/em\u003e, \u003cem\u003eNature Medicine\u003c\/em\u003e and \u003cem\u003eThe Lancet\u003c\/em\u003e \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e. One distinction is worth keeping in mind: those clinical trials were conducted with a pharmaceutical product in patients and under medical supervision. What we offer here is reference material for research, not an approved medicine.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eJastreboff AM, et al. \u003cem\u003eTriple-Hormone-Receptor Agonist Retatrutide for Obesity - A Phase 2 Trial.\u003c\/em\u003e N Engl J Med, 2023. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/37366315\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 37366315\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eSanyal AJ, et al. \u003cem\u003eTriple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial.\u003c\/em\u003e Nat Med, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38858523\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38858523\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eBajaj HS, et al. \u003cem\u003eEfficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes (TRANSCEND-T2D-1): a phase 3 trial.\u003c\/em\u003e Lancet, 2026. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/42250575\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 42250575\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eKatsi V, et al. \u003cem\u003eRetatrutide — A Game Changer in Obesity Pharmacotherapy.\u003c\/em\u003e Biomolecules, 2025. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/40563436\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 40563436\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54603479646537,"sku":"RT15","price":197.9,"currency_code":"EUR","in_stock":false},{"title":"20 mg","offer_id":54603479679305,"sku":"RT20","price":241.9,"currency_code":"EUR","in_stock":true},{"title":"30 mg","offer_id":54760619049289,"sku":"RT30","price":289.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/principal-sin-fondo-removebg-preview.png?v=1782817358"},{"product_id":"ghk-cu-50-mg","title":"GHK Cu","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eGHK-Cu\u003c\/strong\u003e is investigated for its role in \u003cstrong\u003ecollagen and elastin, wound healing, and skin firmness and health\u003c\/strong\u003e. Technically, it is the copper(II) complex of the tripeptide glycyl-L-histidyl-L-lysine, an endogenous molecule naturally present in human plasma, saliva, and urine, which transports copper into the cell and acts as a regenerative modulator, antioxidant, and anti-inflammatory even at nanomolar concentrations. It is probably the most studied copper peptide in regenerative biology.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it investigated for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Collagen and elastin synthesis\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Skin healing and firmness\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Antioxidant and anti-inflammatory defense\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Angiogenesis and extracellular matrix remodeling\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Epigenetic regulation of gene expression\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle \u0026amp; Break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of Action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eExtracellular Matrix Regeneration and Collagen Synthesis\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu activates dermal fibroblasts—the connective tissue cells that produce the extracellular matrix (ECM)—and drives its remodeling. Through the TGF-β signaling pathway, it upregulates type I collagen, elastin, and glycosaminoglycan expression while adjusting the balance between metalloproteinases (MMP1, MMP2) and their tissue inhibitors (TIMP1, TIMP2) to prevent excessive tissue degradation. In wound healing models, collagen synthesis increases by \u003cstrong\u003e70% to 230%\u003c\/strong\u003e, reaching up to nine times in in vitro assays with fibroblasts.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAntioxidant and Anti-inflammatory Action\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt provides bioavailable copper to the enzyme Cu,Zn-SOD1, mimicking superoxide dismutase activity and reducing reactive oxygen species (ROS) such as superoxide and hydroxyl radicals. Additionally, it limits iron release from ferritin (up to 87% inhibition), decreases lipid peroxidation byproducts, and protects against LDL oxidation. On the anti-inflammatory front, it suppresses NF-κB (p65) and p38 MAPK pathways, leading to a reduction in mediators such as TNF-α, IL-6, and fibrinogen.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eStimulation of Angiogenesis\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt promotes the formation of new blood vessels by increasing VEGF and bFGF (FGF2) secretion by fibroblasts and mesenchymal stem cells. Released from the SPARC protein during tissue injury, it promotes endothelial proliferation in early repair phases and moderates it in later phases.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eEpigenetic Modulation of Gene Expression\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu modifies the expression of more than \u003cstrong\u003e1,000 genes\u003c\/strong\u003e—approximately 1,569 upregulated and 583 downregulated—acting as an epigenetic regulator by inhibiting histone deacetylases (HDACs). This reactivates regenerative pathways (TGF-β, integrins, p63) while attenuating gene programs associated with inflammation and tumor processes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific Evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCollagen and Matrix:\u003c\/strong\u003e In vitro studies in fibroblasts and rat wound models document collagen increases of up to 9×, with gene profiles confirming TGF-β pathway activation.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAntioxidant and Anti-inflammatory:\u003c\/strong\u003e UV radiation protection assays in keratinocytes and fibroblast cultures show cytokine decreases; animal models confirm ROS neutralization.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAngiogenesis:\u003c\/strong\u003e Gene data reflects a \u003cstrong\u003e487% increase in ANGPT1 expression\u003c\/strong\u003e; studies in rabbit wounds show greater granulation tissue and vascularization.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGene Regulation:\u003c\/strong\u003e Microarray analyses (e.g., Connectivity Map) show broad effects; in COPD models, the reversal of 127 genes towards a healthier profile has been described.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct Use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to this comprehensive profile, GHK-Cu is a key peptide in research lines on tissue regeneration and wound healing, extracellular matrix and collagen biology, antioxidant defense, and hair follicle signaling. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as high-purity material for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"100 mg","offer_id":54603479712073,"sku":"CU100","price":176.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/ghk-cu-50-mg-sin-fondo.png?v=1782825071"},{"product_id":"klow-blend-80-mg","title":"KLOW","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003eThe \u003cstrong\u003eKLOW\u003c\/strong\u003e blend is investigated for its role in \u003cstrong\u003etissue repair, inflammation, and cell vitality\u003c\/strong\u003e. It brings together four of the most studied regenerative peptides in a single vial—\u003cstrong\u003eBPC-157\u003c\/strong\u003e, \u003cstrong\u003eGHK-Cu\u003c\/strong\u003e, \u003cstrong\u003eTB-500\u003c\/strong\u003e (Tβ4), and \u003cstrong\u003eKPV\u003c\/strong\u003e—designed for combined research into cytoprotection, extracellular matrix remodeling, and inflammation modulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it investigated for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Comprehensive tissue repair\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Inflammation modulation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Extracellular matrix and collagen remodeling\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cytoprotection and cell vitality\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e20–30 days\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e3–4 months\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eBPC-157 — Cytoprotective signaling\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003ePentadecapeptide derived from a gastric protein, studied for its potent cytoprotective and angiogenic activity through the VEGFR2, PI3K-Akt-eNOS, and ERK1\/2 pathways.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGHK-Cu and TB-500 — Matrix and cytoskeleton\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eGHK-Cu upregulates extracellular matrix (collagen, elastin) and antioxidant defense genes; TB-500 reorganizes actin and directs cell migration. Together, they cover two pillars of tissue repair.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eKPV — Inflammation brake\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTripeptide derived from α-MSH that modulates NF-κB and MAPK pathways, with a marked anti-inflammatory effect at mucosal and systemic levels.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eBPC-157:\u003c\/strong\u003e numerous animal models describe accelerated healing of tendons, muscles, bones, and intestines.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGHK-Cu and TB-500:\u003c\/strong\u003e GHK-Cu increases collagen synthesis by 70-230% in wound models; Tβ4 has reached clinical trials for wound healing.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eKPV:\u003c\/strong\u003e preclinical studies in colitis models show reduced inflammation. Honest note: human data for each component is limited, and there are no controlled studies of the combined formulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe KLOW blend concentrates four complementary repair mechanisms into a single reference material for in vitro and laboratory research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it with high-purity components and a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eAdministration\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n\u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eTiming\u003c\/div\u003e\n\n\u003cdiv style=\"font-weight:600;\"\u003eNight \/ post-workout\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n\u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eApplication\u003c\/div\u003e\n\n\u003cdiv style=\"font-weight:600;\"\u003e1 single dose\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA single application, no multiple injections. Designed for easy administration.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"80 mg","offer_id":54545811374409,"sku":"KLOW80","price":198.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/klow-blend-80-mg-sin-fondo.png?v=1782819714"},{"product_id":"tirzepatida-20-mg","title":"TIRZEPATIDE","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eWhat it is\u003c\/p\u003e\n\u003cp style=\"font-size:1.12em;line-height:1.7;margin:0 0 1em;\"\u003eA peptide that mimics \u003cstrong\u003etwo appetite hormones at once\u003c\/strong\u003e instead of one. It is the intermediate step between the classic compounds, which copy only one hormone, and newer ones such as Retatrutide, which copy three.\u003c\/p\u003e\n\u003cp style=\"font-size:1.02em;line-height:1.7;margin:0 0 1.2em;color:#374151;\"\u003eWhen you eat, the gut releases hormones called incretins that signal the pancreas and the brain. Tirzepatide copies two of them: GLP-1, the best known, and GIP. By pressing both keys, the effect on appetite and blood sugar is greater than pressing only one.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat it is used for\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Research on weight and appetite control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Blood glucose control\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Studies comparing it with compounds that copy only one hormone\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Gastric emptying and satiety signals\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it is used\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eContinuous until target\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eNot required\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRoute\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003eWeekly subcutaneous\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eLyophilized powder. It is reconstituted with bacteriostatic water, swirled without shaking, and stored between 2 and 8 °C. In the literature it is administered once a week with gradual dose escalation, which is what makes the digestive effects tolerable \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat has been observed\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;color:#6b7280;font-size:.95em;\"\u003eResults described in the published scientific literature. They are not directions for use or health recommendations.\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In SURPASS-1 (478 adults with type 2 diabetes, 40 weeks), weight loss was dose-dependent and ranged from \u003cstrong\u003e7.0 to 9.5 kg\u003c\/strong\u003e \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  In the same trial, glycated hemoglobin fell by 1.87 to 2.07 points, versus an increase of 0.04 with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Between 87% and 92% of participants reached an HbA1c below 7%, versus 20% with placebo \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  The most frequent adverse effects were digestive, mild or moderate and transient: nausea (12-18% versus 6%), diarrhea and vomiting \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  No severe or clinically significant hypoglycemia was reported with tirzepatide in that study \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\n\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eHow it works\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGIP \/ GLP-1 co-agonism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTirzepatide (LY-3298176) is a single peptide that simultaneously activates the GIP receptor and the GLP-1 receptor \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[2]\u003c\/sup\u003e. The GLP-1 branch acts on the hypothalamic appetite centers, slows gastric emptying and enhances glucose-dependent insulin secretion.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eWhat the GIP branch contributes\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThe role of GIP was debated for years. The hypothesis behind the design is that combined signaling improves insulin sensitivity in adipose tissue and enhances the effect of GLP-1 on intake beyond what GLP-1 achieves alone \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[3]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003ePosition within its family\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eReviews describe it as the co-agonist with the best balance between glycemic control and weight reduction in its generation, and as the reference against which newer agonists are compared \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eState of the evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eClinical and extensive.\u003c\/strong\u003e A complete phase 3 program (SURPASS series) published in \u003cem\u003eThe Lancet\u003c\/em\u003e and reviewed in the endocrinology literature \u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[1]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[4]\u003c\/sup\u003e\u003csup style=\"color:#0099ff;font-weight:600;\"\u003e[5]\u003c\/sup\u003e. As with the rest of the catalog, the material we offer is research grade: the clinical trials cited were conducted with a pharmaceutical product and under medical supervision.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eReferences\u003c\/p\u003e\n\u003col style=\"margin:0;padding-left:1.4em;font-size:.86em;color:#6b7280;line-height:1.7;\"\u003e\n  \u003cli\u003eRosenstock J, et al. \u003cem\u003eEfficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial.\u003c\/em\u003e Lancet, 2021. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/34186022\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 34186022\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eCoskun T, et al. \u003cem\u003eLY3298176, a novel dual GIP and GLP-1 receptor agonist for the treatment of type 2 diabetes mellitus: from discovery to clinical proof of concept.\u003c\/em\u003e Mol Metab, 2018. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/30473097\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 30473097\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eSamms RJ, et al. \u003cem\u003eHow May GIP Enhance the Therapeutic Efficacy of GLP-1?\u003c\/em\u003e Trends Endocrinol Metab, 2020. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/32396843\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 32396843\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eNauck MA, et al. \u003cem\u003eTirzepatide, a dual GIP\/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regarding glycaemic control and body weight reduction.\u003c\/em\u003e Cardiovasc Diabetol, 2022. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/36050763\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 36050763\u003c\/a\u003e\n\u003c\/li\u003e\n  \u003cli\u003eDrucker DJ, et al. \u003cem\u003eEfficacy and Safety of GLP-1 Medicines for Type 2 Diabetes and Obesity.\u003c\/em\u003e Diabetes Care, 2024. \u003ca href=\"https:\/\/pubmed.ncbi.nlm.nih.gov\/38843460\/\" target=\"_blank\" rel=\"nofollow noopener\" style=\"color:#0099ff;text-decoration:none;\"\u003ePubMed 38843460\u003c\/a\u003e\n\u003c\/li\u003e\n\u003c\/ol\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"15 mg","offer_id":54603479777609,"sku":"TR15","price":192.9,"currency_code":"EUR","in_stock":false},{"title":"20 mg","offer_id":54545849286985,"sku":"TR20","price":239.9,"currency_code":"EUR","in_stock":true},{"title":"30 mg","offer_id":54603479810377,"sku":"TR30","price":278.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/tirzepatida-20-mg-sin-fondo.png?v=1782819734"},{"product_id":"nad-1000-mg","title":"NAD+","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eNAD⁺\u003c\/strong\u003e is studied for its role in \u003cstrong\u003ecellular energy, DNA repair and molecular aging\u003c\/strong\u003e. Technically, it is the coenzyme nicotinamide adenine dinucleotide, present in every cell and central to energy production, redox reactions and cell signaling; its levels \u003cstrong\u003edecline with age\u003c\/strong\u003e, which has made it a key target in longevity research.\u003c\/p\u003e\n\n\u003cp data-pbg-nad style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eNAD⁺ is not the same as NAD\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003e“NAD” on its own is the name of the molecule, which exists in the body in two forms: \u003cstrong\u003eNAD⁺\u003c\/strong\u003e and \u003cstrong\u003eNADH\u003c\/strong\u003e. The “+” sign is not decoration: it marks the active form, the one the cell has free to work with.\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.1em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n\u003cdiv style=\"font-weight:600;\"\u003eNAD⁺ · the active form\u003c\/div\u003e\n\u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eIt collects energy from nutrients and is the form consumed by the enzymes that repair DNA. It is also the form that declines with age.\u003c\/div\u003e\n\u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;text-align:left;\"\u003e\n\u003cdiv style=\"font-weight:600;\"\u003eNADH · the already-loaded form\u003c\/div\u003e\n\u003cdiv style=\"font-size:.92em;color:#4b5563;line-height:1.5;margin-top:3px;\"\u003eIt carries that energy to the mitochondria. It does not serve as raw material for cellular repair.\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis vial contains \u003cstrong\u003eNAD⁺ as is\u003c\/strong\u003e: not NADH, nor a precursor such as NMN or NR that the body would first have to convert. That is why it is the most researched form, mainly for three reasons: \u003cstrong\u003eenergy\u003c\/strong\u003e (it is essential for producing ATP), \u003cstrong\u003erepair\u003c\/strong\u003e (it fuels the enzymes that fix DNA) and \u003cstrong\u003eaging\u003c\/strong\u003e (its levels fall over the years).\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Cellular energy production (ATP)\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  DNA repair and sirtuin activity\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Mitochondrial function and biogenesis\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Molecular aging and longevity\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4–8 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e2–4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDriver of cellular energy\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt acts as a cofactor in glycolysis, the Krebs cycle and oxidative phosphorylation, transferring electrons in the oxidation-reduction reactions that generate ATP.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eDNA repair and sirtuins\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is the substrate for sirtuins and PARP enzymes, which are involved in DNA repair, chromatin regulation and mitochondrial biogenesis.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eHomeostasis and signaling\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt regulates pathways of calcium homeostasis, inflammation and chromatin remodeling.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCellular metabolism:\u003c\/strong\u003e It is one of the most widely used cofactors in cellular metabolism.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eAging:\u003c\/strong\u003e Its decline is associated with greater DNA damage, oxidative stress and mitochondrial dysfunction in aging models.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNAD⁺ availability:\u003c\/strong\u003e Researched alongside modulators such as 5-Amino-1MQ for its role in NAD⁺ availability.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eNAD⁺ is a core reference material in research on energy metabolism, mitochondria and longevity. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it in research grade, with a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"500 mg","offer_id":55126422454601,"sku":"NJ500","price":178.9,"currency_code":"EUR","in_stock":true},{"title":"1000 mg","offer_id":54545849319753,"sku":"NJ1000","price":248.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/nad-1000-mg-sin-fondo.png?v=1782819737"},{"product_id":"mots-c-20-mg","title":"MOTS C","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eMOTS-c\u003c\/strong\u003e is studied as a \u003cstrong\u003emetabolic regulator\u003c\/strong\u003e: it improves physical endurance, insulin sensitivity, and the conversion of fat to energy. Technically, it is a 16-amino acid mitochondrial peptide, encoded by mitochondrial DNA itself and discovered in 2015, which is considered an \u003cstrong\u003e\"exercise mimetic\"\u003c\/strong\u003e due to its ability to improve metabolic efficiency.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Metabolic efficiency and physical endurance\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Insulin sensitivity and glucose metabolism\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Conversion of fat to energy\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Metabolic aging and neuroprotection\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4–6 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAMPK activation and metabolism\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates the AMPK pathway, the cell's master energy sensor, and regulates purine and glucose metabolism, promoting mitochondrial efficiency.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMitochondria-nucleus communication\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is one of the few peptides that translocates from the mitochondria to the nucleus to directly modulate gene expression in response to metabolic stress.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eAging and neuroprotection\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being investigated in metabolic disorders, age-related conditions, and neurodegenerative diseases.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMetabolism:\u003c\/strong\u003e Studies describe improved insulin sensitivity and glucose metabolism, replicating exercise effects.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eNuclear translocation:\u003c\/strong\u003e Its nuclear translocation under cellular stress has been documented since its discovery (Lee et al., 2015).\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eLongevity and neuroprotection:\u003c\/strong\u003e Preclinical models support effects on metabolic longevity and neuroprotection.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAs a mitochondria-derived peptide with exercise mimetic action, MOTS-c is a unique reference material in metabolism and aging research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we offer it as a high-purity peptide, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":55126422421833,"sku":"MS10","price":103.9,"currency_code":"EUR","in_stock":true},{"title":"40 mg","offer_id":54545849483593,"sku":"MS40","price":178.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/mots-c-20-mg-sin-fondo.png?v=1782819744"},{"product_id":"pt-141","title":"PT 141","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003ePT-141\u003c\/strong\u003e is one of the reference peptides in the field of \u003cstrong\u003esexual function and neuroendocrinology\u003c\/strong\u003e: it is being researched for its role in \u003cstrong\u003esexual desire and response through the central nervous system\u003c\/strong\u003e. Technically, it is a cyclic 7-amino acid peptide, an analog of α-MSH, which acts as an agonist of melanocortin receptors (mainly MC4R and MC1R) and, unlike vascular modulators, exerts its action at the central level.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Central-origin sexual desire and response\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Female and male sexual function\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Biology of the melanocortin system\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Hypothalamic MC4R receptor signaling\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003ePunctual use\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eNot applicable\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanocortin receptor agonism (MC4R\/MC1R)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt activates melanocortin receptors in the central nervous system, especially hypothalamic MC4R, a pathway involved in regulating sexual desire independent of the vascular route.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCentral, not vascular, pathway\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIts mechanism differs from that of PDE5 inhibitors: instead of acting on blood flow, it modulates brain signals associated with arousal.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eResearch in sexual function\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is being researched in both female and male sexual dysfunction, as well as in the biology of the melanocortin system.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCentral mechanism:\u003c\/strong\u003e PT-141 was approved by the FDA in 2019 (Vyleesi) for hypoactive sexual desire in premenopausal women, which supports its central mechanism of action.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003ePhase 3 trials:\u003c\/strong\u003e Phase 3 clinical trials (RECONNECT program) documented an increase in sexual desire compared to placebo.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eSexual function:\u003c\/strong\u003e Clinical programs have evaluated its effect on sexual response in both sexes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its central mechanism via the melanocortin system, PT-141 is a unique reference material for research into sexual function and neuroendocrinology. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a certificate of analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not suitable for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54603569135945,"sku":"PT41","price":85.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/pt-141-sin-fondo.png?v=1782819771"},{"product_id":"melanotan-ii","title":"MELANOTAN II","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eMelanotan II\u003c\/strong\u003e is one of the most studied peptides in the field of \u003cstrong\u003epigmentation and the melanocortin system\u003c\/strong\u003e: it is researched for its role in \u003cstrong\u003emelanogenesis (melanin production) and melanocortin receptor biology\u003c\/strong\u003e. Technically, it is a cyclic synthetic α-MSH analog and a non-selective agonist of melanocortin receptors (MC1R, MC3R, MC4R, and MC5R).\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Melanogenesis and skin pigmentation\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  UV radiation-independent photoprotection\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Melanocortin receptor biology\u003c\/li\u003e\n\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Central signaling via MC4R\u003c\/li\u003e\n\n\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and rest\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eLoading phase + maintenance\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eRest\u003c\/div\u003e\n\n    \u003cdiv style=\"font-weight:600;\"\u003eVariable\u003c\/div\u003e\n\n  \u003c\/div\u003e\n\n\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanogenesis via MC1R\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eActivation of the MC1R receptor in melanocytes stimulates eumelanin synthesis, which is the basis for its study in skin pigmentation and photoprotection.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMelanocortin system (MC4R)\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eAs a non-selective agonist, it also acts on MC4R, a pathway involved in appetite regulation and sexual function.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eResearch in pigmentation\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is researched in the context of pigmentation, photoprotection, and the biology of various melanocortin receptors.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMelanogenesis:\u003c\/strong\u003e Studies describe an increase in MC1R-mediated melanogenesis, independent of UV radiation exposure.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eMelanocortin system:\u003c\/strong\u003e Preclinical models document effects on the central melanocortin system.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eReceptor affinity:\u003c\/strong\u003e Literature describes its affinity for multiple melanocortin receptor subtypes.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eDue to its action on melanogenesis and the melanocortin system, Melanotan II is a prominent reference material in research on pigmentation and melanocortin receptors. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e, we supply it as a high-purity peptide for laboratory use, with a Certificate of Analysis (COA) available upon request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"PeptidoBioGenetic","offers":[{"title":"10 mg","offer_id":54603569168713,"sku":"MT2","price":81.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/melanotan-ii-sin-fondo.png?v=1782819774"},{"product_id":"cjc-1295-ipamorelin-20-mg","title":"CJC 1295 + IPAMORELIN","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003eThe \u003cstrong\u003eCJC-1295 without DAC + Ipamorelin\u003c\/strong\u003e blend is researched for its role in the \u003cstrong\u003epulsatile release of the body's own growth hormone\u003c\/strong\u003e. It combines in a single vial a GHRH analog and a selective ghrelin receptor agonist: two different pathways that converge on the pituitary gland.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Pulsatile secretion of endogenous GH\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  GH \/ IGF-1 axis\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and recovery\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Deep sleep quality\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e8–12 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e4 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eCJC-1295 without DAC — GHRH analog\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA modified version of the GRF(1-29) fragment that binds to the pituitary GHRH receptor and amplifies the amplitude of the GH pulse. Without DAC technology its half-life is short, so it respects the natural pulsatile pattern.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eIpamorelin — selective ghrelin agonist\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eA pentapeptide that activates the GHS-R1a receptor. Its distinguishing feature is selectivity: unlike classic GHRPs, it barely raises cortisol or prolactin.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSynergy at the pituitary\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eEach component acts on a different receptor. When combined, an additive effect on the GH pulse is studied that is greater than that of either one alone.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eCJC-1295:\u003c\/strong\u003e Studies with the GRF(1-29) fragment document dose-dependent increases in GH and IGF-1 in healthy subjects.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eIpamorelin:\u003c\/strong\u003e Described in the literature as the most selective secretagogue in its family, with a clean endocrine profile.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eSynergy:\u003c\/strong\u003e The GHRH + GHRP combination is a classic in research on the somatotropic axis. An honest note: there are no controlled human studies of this specific combined formulation.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eThis blend brings together the two complementary secretagogue mechanisms in a single reference material for in vitro and laboratory research. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it with high-purity components and a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"Peptido Biogenetic","offers":[{"title":"20 mg","offer_id":55005233905993,"sku":"CP20","price":230.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/cjc-1295-ipamorelin-20-mg-sin-fondo.png?v=1787687081"},{"product_id":"hgh-191aa-36-iu","title":"HGH 191AA","description":"\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:0 0 .4em;font-family:inherit;\"\u003eSummary\u003c\/p\u003e\n\u003cp style=\"font-size:1.05em;line-height:1.65;margin:0 0 1.2em;\"\u003e\u003cstrong\u003eHGH 191AA\u003c\/strong\u003e is somatropin: \u003cstrong\u003efull-sequence recombinant human growth hormone\u003c\/strong\u003e, with its 191 amino acids identical to those of the endogenous molecule. Unlike secretagogues, it supplies the hormone directly instead of stimulating the pituitary to release it.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eWhat is it researched for?\u003c\/p\u003e\n\u003cul style=\"margin:0 0 1.2em;padding-left:0;list-style:none;line-height:1.9;\"\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  GH \/ IGF-1 axis and somatotropic signaling\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Body composition and protein turnover\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Lipid and glucose metabolism\u003c\/li\u003e\n  \u003cli style=\"padding-left:1.3em;text-indent:-1.3em;margin:0;\"\u003e\n\u003cspan style=\"color:#0099ff;font-weight:700;\"\u003e•\u003c\/span\u003e  Tissue recovery and repair\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eCycle and break\u003c\/p\u003e\n\u003cdiv style=\"display:flex;gap:12px;margin:0 0 1.4em;flex-wrap:wrap;\"\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eCycle\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e12–24 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n  \u003cdiv style=\"flex:1;min-width:150px;padding:12px 16px;background:#f6f6f7;border-radius:10px;\"\u003e\n    \u003cdiv style=\"font-size:.72em;text-transform:uppercase;letter-spacing:.08em;color:#9ca3af;margin-bottom:2px;\"\u003eBreak\u003c\/div\u003e\n    \u003cdiv style=\"font-weight:600;\"\u003e6–8 weeks\u003c\/div\u003e\n  \u003c\/div\u003e\n\u003c\/div\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eMechanism of action\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eSomatropin — complete 191AA sequence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eProduced by recombinant DNA technology, it reproduces the 191-amino-acid chain of human GH. The 191AA designation distinguishes it from 192-amino-acid variants, which carry an extra methionine.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eGH receptor pathway\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt binds to the GH receptor and activates the JAK2\/STAT5 cascade, which induces hepatic production of IGF-1, the main mediator of its peripheral effects.\u003c\/p\u003e\n\u003cp style=\"margin:1.1em 0 0.3em;font-weight:600;font-family:inherit;\"\u003eMeasured in international units\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eIt is quantified in IU rather than milligrams, the standard convention for protein hormones. For reference, 1 mg is approximately equivalent to 3 IU.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eScientific evidence\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eWell-characterized molecule:\u003c\/strong\u003e Recombinant somatropin is one of the best-described therapeutic proteins in modern pharmacology, in clinical use since the 1980s.\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.7em;padding:10px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e\u003cstrong\u003eGH \/ IGF-1 axis:\u003c\/strong\u003e The literature documents in detail the dose-response relationship between exogenous GH and circulating IGF-1 levels.\u003c\/p\u003e\n\n\u003cp style=\"font-size:.8em;letter-spacing:.12em;text-transform:uppercase;color:#9ca3af;font-weight:600;margin:1.9em 0 .6em;font-family:inherit;\"\u003eProduct use\u003c\/p\u003e\n\u003cp style=\"margin:0 0 0.9em;line-height:1.6;\"\u003eTop-tier reference material for in vitro and laboratory research on the somatotropic axis. At \u003cstrong\u003ePeptido BioGenetic\u003c\/strong\u003e we offer it with high-purity components and a certificate of analysis (COA) available on request.\u003c\/p\u003e\n\n\u003cp style=\"margin:1.6em 0 0;padding:12px 14px;background:#f3f4f6;border-radius:8px;font-size:.92em;color:#4b5563;line-height:1.5;\"\u003e⚠️ Product intended exclusively for \u003cstrong\u003eresearch and laboratory use\u003c\/strong\u003e. Not for human or veterinary consumption.\u003c\/p\u003e","brand":"Peptido Biogenetic","offers":[{"title":"36 IU","offer_id":55005234069833,"sku":"H36","price":242.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/1016\/7507\/3865\/files\/hgh-191aa-36-iu-sin-fondo.png?v=1787687101"}],"url":"https:\/\/www.peptidobiogenetic.com\/en-us\/collections\/mas-vendidos.oembed","provider":"PeptidoBioGenetic","version":"1.0","type":"link"}